Annual D&A
$35.64 M
-$15.73 M-30.62%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual depreciation & amortization is currently $35.64 million, with the most recent change of -$15.73 million (-30.62%) on 31 December 2023. During the last 3 years, it has risen by +$7.68 million (+27.45%). LGND annual D&A is now -30.62% below its all-time high of $51.37 million, reached on 31 December 2022.LGND Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$8.99 M
+$141.00 K+1.59%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization is currently $8.99 million, with the most recent change of +$141.00 thousand (+1.59%) on 30 September 2024. Over the past year, it has increased by +$383.00 thousand (+4.45%). LGND quarterly D&A is now -59.18% below its all-time high of $22.04 million, reached on 31 December 2019.LGND Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$34.65 M
+$383.00 K+1.12%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM depreciation & amortization is currently $34.65 million, with the most recent change of +$383.00 thousand (+1.12%) on 30 September 2024. Over the past year, it has dropped by -$4.09 million (-10.56%). LGND TTM D&A is now -34.85% below its all-time high of $53.18 million, reached on 30 September 2022.LGND TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.6% | +4.5% | -10.6% |
| 3 y3 years | +27.4% | -28.7% | -31.8% |
| 5 y5 years | +142.2% | +5.3% | +38.6% |
LGND Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -30.6% | +27.4% | -34.1% | +11.9% | -34.9% | +1.1% |
| 5 y | 5 years | -30.6% | +142.2% | -59.2% | +113.0% | -34.9% | +38.6% |
| alltime | all time | -30.6% | +3288.1% | -59.2% | +357.0% | -34.9% | +6074.1% |
Ligand Pharmaceuticals Incorporated Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.99 M(+1.6%) | $34.65 M(+1.1%) |
| June 2024 | - | $8.85 M(+1.0%) | $34.27 M(-1.8%) |
| Mar 2024 | - | $8.77 M(+9.0%) | $34.91 M(-2.1%) |
| Dec 2023 | $35.64 M(-30.6%) | $8.04 M(-6.7%) | $35.64 M(-8.0%) |
| Sept 2023 | - | $8.61 M(-9.3%) | $38.74 M(-11.2%) |
| June 2023 | - | $9.49 M(-0.0%) | $43.63 M(-7.6%) |
| Mar 2023 | - | $9.50 M(-14.7%) | $47.23 M(-8.1%) |
| Dec 2022 | $51.37 M(+0.8%) | $11.13 M(-17.6%) | $51.37 M(-3.4%) |
| Sept 2022 | - | $13.51 M(+3.2%) | $53.18 M(+1.7%) |
| June 2022 | - | $13.09 M(-4.1%) | $52.29 M(+1.5%) |
| Mar 2022 | - | $13.64 M(+5.4%) | $51.50 M(+1.1%) |
| Dec 2021 | $50.95 M(+82.2%) | $12.95 M(+2.7%) | $50.95 M(+0.3%) |
| Sept 2021 | - | $12.61 M(+2.6%) | $50.81 M(+18.9%) |
| June 2021 | - | $12.29 M(-6.1%) | $42.75 M(+23.3%) |
| Mar 2021 | - | $13.09 M(+2.2%) | $34.68 M(+24.0%) |
| Dec 2020 | $27.97 M(-36.0%) | $12.82 M(+181.8%) | $27.97 M(-24.8%) |
| Sept 2020 | - | $4.55 M(+7.7%) | $37.19 M(-9.7%) |
| June 2020 | - | $4.22 M(-33.8%) | $41.18 M(-6.0%) |
| Mar 2020 | - | $6.38 M(-71.0%) | $43.83 M(+0.2%) |
| Dec 2019 | $43.73 M(+197.1%) | $22.04 M(+157.9%) | $43.73 M(+75.0%) |
| Sept 2019 | - | $8.54 M(+24.3%) | $24.99 M(+14.3%) |
| June 2019 | - | $6.87 M(+9.5%) | $21.86 M(+21.5%) |
| Mar 2019 | - | $6.28 M(+90.4%) | $17.99 M(+22.3%) |
| Dec 2018 | $14.72 M(+25.6%) | $3.30 M(-39.0%) | $14.72 M(-5.4%) |
| Sept 2018 | - | $5.41 M(+79.6%) | $15.55 M(+27.9%) |
| June 2018 | - | $3.01 M(+0.3%) | $12.16 M(+3.6%) |
| Mar 2018 | - | $3.00 M(-27.4%) | $11.74 M(+0.2%) |
| Dec 2017 | $11.71 M(+3.8%) | $4.13 M(+104.9%) | $11.71 M(+11.0%) |
| Sept 2017 | - | $2.02 M(-22.0%) | $10.55 M(-8.0%) |
| June 2017 | - | $2.58 M(-13.2%) | $11.47 M(-1.9%) |
| Mar 2017 | - | $2.98 M(+0.4%) | $11.69 M(+3.6%) |
| Dec 2016 | $11.29 M(+329.8%) | $2.97 M(+1.2%) | $11.29 M(+25.3%) |
| Sept 2016 | - | $2.93 M(+4.3%) | $9.01 M(+34.1%) |
| June 2016 | - | $2.81 M(+9.2%) | $6.72 M(+47.6%) |
| Mar 2016 | - | $2.58 M(+274.8%) | $4.55 M(+73.3%) |
| Dec 2015 | $2.63 M(-1.1%) | $687.00 K(+6.7%) | $2.63 M(+1.1%) |
| Sept 2015 | - | $644.00 K(-0.3%) | $2.60 M(-0.6%) |
| June 2015 | - | $646.00 K(-0.6%) | $2.62 M(-0.9%) |
| Mar 2015 | - | $650.00 K(-1.4%) | $2.64 M(-0.7%) |
| Dec 2014 | $2.66 M(-0.2%) | $659.00 K(-0.3%) | $2.66 M(+0.1%) |
| Sept 2014 | - | $661.00 K(-1.2%) | $2.65 M(-0.3%) |
| June 2014 | - | $669.00 K(+0.1%) | $2.66 M(0.0%) |
| Mar 2014 | - | $668.00 K(+1.8%) | $2.66 M(-0.1%) |
| Dec 2013 | $2.66 M(-2.3%) | $656.00 K(-1.8%) | $2.66 M(-3.4%) |
| Sept 2013 | - | $668.00 K(-0.1%) | $2.76 M(+1.1%) |
| June 2013 | - | $669.00 K(-0.1%) | $2.73 M(+0.3%) |
| Mar 2013 | - | $670.00 K(-10.5%) | $2.72 M(-0.3%) |
| Dec 2012 | $2.73 M(-2.3%) | $749.00 K(+17.4%) | $2.73 M(+2.2%) |
| Sept 2012 | - | $638.00 K(-3.6%) | $2.67 M(-4.0%) |
| June 2012 | - | $662.00 K(-2.4%) | $2.78 M(-4.2%) |
| Mar 2012 | - | $678.00 K(-1.9%) | $2.90 M(+4.1%) |
| Dec 2011 | $2.79 M(+26.1%) | $691.00 K(-7.9%) | $2.79 M(+27.2%) |
| Sept 2011 | - | $750.00 K(-4.5%) | $2.19 M(+3.8%) |
| June 2011 | - | $785.00 K(+39.2%) | $2.11 M(+4.0%) |
| Mar 2011 | - | $564.00 K(+493.7%) | $2.03 M(-8.2%) |
| Dec 2010 | $2.21 M(-29.4%) | $95.00 K(-85.8%) | $2.21 M(-23.2%) |
| Sept 2010 | - | $669.00 K(-4.8%) | $2.88 M(-3.7%) |
| June 2010 | - | $703.00 K(-5.6%) | $2.99 M(-2.2%) |
| Mar 2010 | - | $745.00 K(-2.5%) | $3.06 M(-2.4%) |
| Dec 2009 | $3.13 M | $764.00 K(-2.2%) | $3.13 M(+20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $781.00 K(+1.4%) | $2.61 M(-15.2%) |
| June 2009 | - | $770.00 K(-6.0%) | $3.08 M(+95.5%) |
| Mar 2009 | - | $819.00 K(+244.1%) | $1.57 M(+49.5%) |
| Dec 2008 | $1.05 M(-38.3%) | $238.00 K(-80.9%) | $1.05 M(+291.1%) |
| Sept 2008 | - | $1.25 M(-270.5%) | $269.00 K(-146.4%) |
| June 2008 | - | -$732.00 K(-345.6%) | -$580.00 K(-153.2%) |
| Mar 2008 | - | $298.00 K(-154.7%) | $1.09 M(-36.1%) |
| Dec 2007 | $1.71 M(-89.5%) | -$545.00 K(-236.6%) | $1.71 M(-65.5%) |
| Sept 2007 | - | $399.00 K(-57.5%) | $4.94 M(-43.3%) |
| June 2007 | - | $938.00 K(+2.6%) | $8.71 M(-29.8%) |
| Mar 2007 | - | $914.00 K(-66.0%) | $12.40 M(-23.5%) |
| Dec 2006 | $16.22 M(-13.3%) | $2.69 M(-35.5%) | $16.22 M(-11.4%) |
| Sept 2006 | - | $4.17 M(-10.0%) | $18.31 M(-3.1%) |
| June 2006 | - | $4.63 M(-2.0%) | $18.88 M(-0.5%) |
| Mar 2006 | - | $4.73 M(-1.0%) | $18.98 M(+1.4%) |
| Dec 2005 | $18.71 M(+22.5%) | $4.78 M(+0.6%) | $18.71 M(+4.7%) |
| Sept 2005 | - | $4.75 M(+0.5%) | $17.88 M(+5.2%) |
| June 2005 | - | $4.72 M(+5.9%) | $17.00 M(+6.7%) |
| Mar 2005 | - | $4.46 M(+13.0%) | $15.92 M(+4.2%) |
| Dec 2004 | $15.28 M(+6.6%) | $3.94 M(+1.9%) | $15.28 M(+2.1%) |
| Sept 2004 | - | $3.87 M(+6.0%) | $14.96 M(+2.3%) |
| June 2004 | - | $3.65 M(-4.2%) | $14.62 M(+0.8%) |
| Mar 2004 | - | $3.81 M(+5.0%) | $14.51 M(+1.3%) |
| Dec 2003 | $14.33 M(+64.3%) | $3.63 M(+2.8%) | $14.33 M(+0.2%) |
| Sept 2003 | - | $3.53 M(-0.3%) | $14.30 M(+14.0%) |
| June 2003 | - | $3.54 M(-2.4%) | $12.55 M(+17.0%) |
| Mar 2003 | - | $3.63 M(+0.6%) | $10.73 M(+23.0%) |
| Dec 2002 | $8.72 M(+32.7%) | $3.61 M(+103.4%) | $8.72 M(+35.3%) |
| Sept 2002 | - | $1.77 M(+3.1%) | $6.45 M(+1.0%) |
| June 2002 | - | $1.72 M(+5.8%) | $6.38 M(-1.8%) |
| Mar 2002 | - | $1.62 M(+22.0%) | $6.50 M(-1.1%) |
| Dec 2001 | $6.57 M(-9.3%) | $1.33 M(-22.2%) | $6.57 M(-5.2%) |
| Sept 2001 | - | $1.71 M(-6.8%) | $6.93 M(+197.9%) |
| June 2001 | - | $1.83 M(+8.1%) | $2.33 M(-48.5%) |
| Mar 2001 | - | $1.70 M(+0.5%) | $4.52 M(-37.6%) |
| Dec 2000 | $7.25 M(+2.0%) | $1.69 M(-158.4%) | $7.25 M(+252.4%) |
| Sept 2000 | - | -$2.89 M(-171.9%) | $2.06 M(-77.3%) |
| June 2000 | - | $4.03 M(-9.0%) | $9.05 M(+7.4%) |
| Mar 2000 | - | $4.42 M(-226.4%) | $8.42 M(+18.6%) |
| Dec 1999 | $7.10 M(+57.8%) | -$3.50 M(-185.4%) | $7.10 M(-26.8%) |
| Sept 1999 | - | $4.10 M(+20.6%) | $9.70 M(+31.1%) |
| June 1999 | - | $3.40 M(+9.7%) | $7.40 M(+27.6%) |
| Mar 1999 | - | $3.10 M(-444.4%) | $5.80 M(+28.9%) |
| Dec 1998 | $4.50 M(-54.1%) | -$900.00 K(-150.0%) | $4.50 M(-44.4%) |
| Sept 1998 | - | $1.80 M(0.0%) | $8.10 M(-8.0%) |
| June 1998 | - | $1.80 M(0.0%) | $8.80 M(-5.4%) |
| Mar 1998 | - | $1.80 M(-33.3%) | $9.30 M(-5.1%) |
| Dec 1997 | $9.80 M(+4.3%) | $2.70 M(+8.0%) | $9.80 M(+2.1%) |
| Sept 1997 | - | $2.50 M(+8.7%) | $9.60 M(-17.9%) |
| June 1997 | - | $2.30 M(0.0%) | $11.70 M(+10.4%) |
| Mar 1997 | - | $2.30 M(-8.0%) | $10.60 M(+12.8%) |
| Dec 1996 | $9.40 M(+154.1%) | $2.50 M(-45.7%) | $9.40 M(+36.2%) |
| Sept 1996 | - | $4.60 M(+283.3%) | $6.90 M(+200.0%) |
| June 1996 | - | $1.20 M(+9.1%) | $2.30 M(+109.1%) |
| Mar 1996 | - | $1.10 M(+57.1%) | $1.10 M(-60.7%) |
| Dec 1995 | $3.70 M(+48.0%) | - | - |
| Mar 1995 | - | $700.00 K(-50.0%) | $2.80 M(+12.0%) |
| Dec 1994 | $2.50 M | $1.40 M(+250.0%) | $2.50 M(+127.3%) |
| Sept 1994 | - | $400.00 K(+33.3%) | $1.10 M(+57.1%) |
| June 1994 | - | $300.00 K(-25.0%) | $700.00 K(+75.0%) |
| Mar 1994 | - | $400.00 K | $400.00 K |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?
The current annual D&A of LGND is $35.64 M
What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual depreciation & amortization is $51.37 M
What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?
Over the past year, LGND annual depreciation & amortization has changed by -$15.73 M (-30.62%)
What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?
The current quarterly D&A of LGND is $8.99 M
What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly depreciation & amortization is $22.04 M
What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?
Over the past year, LGND quarterly depreciation & amortization has changed by +$383.00 K (+4.45%)
What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?
The current TTM D&A of LGND is $34.65 M
What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM depreciation & amortization is $53.18 M
What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?
Over the past year, LGND TTM depreciation & amortization has changed by -$4.09 M (-10.56%)